ARE vs ZVRA · P/E 100, rev $662.8M vs P/E 6.3, rev $75.9M
Alexandria Real Estate Equities Inc (ARE) versus Zevra Therapeutics Inc. (ZVRA) — a side-by-side from cached financials, not a winner call.
Alexandria Real Estate Equities Inc (ARE) is a reit - office company listed on US.
Zevra Therapeutics Inc. (ZVRA) is a biotechnology company listed on NASDAQ.
Latest reported ARE revenue for 2026-06-30 was $662.8M. Net income was -$72.8M. Revenue was down 1.2% from 2026-03-31 to 2026-06-30. ARE currently screens at market cap $13.19B and trailing P/E 100.4.
Latest reported ZVRA revenue for 2026-06-30 was $75.9M. Net income was $46.6M. ZVRA currently screens at market cap $745.4M and trailing P/E 6.3.
ARE currently screens at market cap $13.19B and trailing P/E 100.4. ZVRA currently screens at market cap $745.4M and trailing P/E 6.3.
Not investment advice. Open the ARE and ZVRA stock pages for the full models.
Not investment advice.